EMEA-001834-PIP02-16-M01

Key facts

Invented name
Dexxience
Active substance
Betrixaban
Therapeutic area
Cardiovascular diseases
Decision number
P/0168/2018
PIP number
EMEA-001834-PIP02-16-M01
Pharmaceutical form(s)
  • Capsule, hard
  • Age appropriate formulation
Condition(s) / indication(s)
Prevention of venous thromboembolism
Route(s) of administration
Oral use
Contact for public enquiries
Portola Pharma UK Limited

E-mail: info@portola.com
Tel. +1 6502 467000

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating